QUARTERLY RESULTS
Dr. Reddy's Laboratories Ltd.
BSE
Jun 20
1325.45
-0.95 ( -0.07%)
Volume
36220
Prev. Close
1326.40
Open Price
1327.05
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 20
1325.30
-0.80 ( -0.06%)
Volume
1843895
Prev. Close
1326.10
Open Price
1332.40
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Quarterly Results
for the last 5 years.
|
ISIN No
|
INE089A01031
|
Market Cap. ( ₹ in Cr. )
|
110605.71
|
P/BV
|
3.60
|
Book Value ( ₹ )
|
368.45
|
|
BSE Code
|
500124
|
52 Week High/Low ( ₹ )
|
1421/1020
|
FV/ML
|
1/1
|
P/E(X)
|
19.56
|
|
NSE Code
|
DRREDDYEQ
|
Book Closure
|
10/07/2025
|
EPS ( ₹ )
|
67.76
|
Div Yield (%)
|
0.60
|
(₹ in Crs.)
| Net Sales/Income from operations | 5546.30 | 5015.00 | 6696.30 | 5841.20 | 5081.80 |
| Other Operating Income | 16.60 | 0.00 | 0.00 | 0.00 | 23.00 |
| Total Income From Operations | 5562.90 | 5015.00 | 6696.30 | 5841.20 | 5104.80 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 942.60 | 1011.70 | 934.30 | 911.10 | 907.70 |
| Purchase of Traded Goods | 534.70 | 508.40 | 656.50 | 740.30 | 546.30 |
| Increase/Decrease in Stocks | 82.20 | -37.00 | -93.00 | -126.10 | -52.00 |
| Employees Cost | 797.10 | 794.40 | 840.10 | 855.90 | 779.50 |
| Depreciation | 264.50 | 265.10 | 260.00 | 249.80 | 246.20 |
| Provisions And Contingencies | 103.60 | 0.00 | 0.00 | 0.00 | 26.00 |
| Other Expenses | 1659.70 | 1545.10 | 1636.80 | 1507.00 | 1518.70 |
| Total Expenses | 4384.40 | 4087.70 | 4234.70 | 4138.00 | 3972.40 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 1178.50 | 927.30 | 2461.60 | 1703.20 | 1132.40 |
| Other Income | 414.40 | 235.40 | 207.60 | 217.80 | 212.70 |
| P/L Before Interest, Excpt. Items & Tax | 1592.90 | 1162.70 | 2669.20 | 1921.00 | 1345.10 |
| Interest | 31.10 | 43.30 | 28.40 | 7.10 | 5.90 |
| P/L Before Exceptional Items & Tax | 1561.80 | 1119.40 | 2640.80 | 1913.90 | 1339.20 |
| P/L Before Tax | 1561.80 | 1119.40 | 2640.80 | 1913.90 | 1339.20 |
| Tax | 361.10 | 270.00 | 758.70 | 496.70 | 304.40 |
| P/L After Tax from Ordinary Activities | 1200.70 | 849.40 | 1882.10 | 1417.20 | 1034.80 |
| Net Profit/Loss For the Period | 1200.70 | 849.40 | 1882.10 | 1417.20 | 1034.80 |
| | | | | | |
| Equity Share Capital | 83.40 | 83.40 | 83.40 | 83.40 | 83.40 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 14.41 | 10.20 | 112.84 | 85.10 | 62.14 |
| Diluted EPS (Rs.) | 14.39 | 10.18 | 112.84 | 84.97 | 62.04 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 14.41 | 10.20 | 112.84 | 85.10 | 62.14 |
| Diluted EPS (Rs.) | 14.39 | 10.18 | 112.84 | 84.97 | 62.04 |
| | | | | | |
| PBITOE Margin (%) | 21.18 | 18.49 | 36.76 | 29.15 | 22.18 |
| PBTE Margin (%) | 28.07 | 22.32 | 39.43 | 32.76 | 26.23 |
| PBT Margin (%) | 28.07 | 22.32 | 39.43 | 32.76 | 26.23 |
| PAT Margin (%) | 21.58 | 16.93 | 28.10 | 24.26 | 20.27 |